Quantifying the mutational landscape of retroviral and lentiviral vectors in gene therapy patients
Molecular Therapy · 2025-09 · 33 (9) · 4459-4470
DOI: 10.1016/j.ymthe.2025.05.034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2025-09. Verfasst von Kevyn L Hart und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. Hauptthemen laut MEDLINE: Genetic Vectors, Lentivirus, Genetic Therapy, Mutation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Adenosine deaminase severe combined immunodeficiency (ADA-SCID) is a monogenic disorder caused by mutations in the ADA gene. Gene therapy using γ-retroviral and lentiviral vector gene addition approaches have shown curative results. We sequenced the ADA transgene in transduced CD3+ T cells, and in peripheral blood cells from patients treated with autologous CD34+ cells transduced with either a γ-retroviral or lentiviral ADA gene vector to assess transgene mutational profiles. In both CD3+ T cells and ADA-SCID patients' cells treated with the lentiviral vector, we observed significantly higher occurrences of guanine (G)-to-adenosine (A) base substitutions than with the γ-retroviral vector. We hypothesized that this G-to-A mutational signature was due to the APOBEC3 cytosine deaminase protein family. By knocking out APOBEC3 genes in HEK239T packaging cells, APOBEC3-mediated mutagenesis decreased by 91.2% along the transgene in CD34+ transduced cells in comparison to CD34+ cells transduced with lentiviral supernatant packaged in parental HEK293T cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
- Molecular Biology Interdepartmental Program, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
- Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095, USA.
- Department of Psychiatry, Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA 90095, USA; The Collaboratory, Institute for Qua…
- The Collaboratory, Institute for Quantitative and Computational Biosciences, University of California, Los Angeles, Los Angeles, CA 90095, USA.
- Department of Pediatrics, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095, USA.
Förderung
- NIDDK NIH HHS
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
- University of California Los Angeles Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research
- Clinical and Translational Science Institute, University of California, Los Angeles
- National Institutes of Health
Zitieren
APA
Hart, K. L., Crisostomo, R. V., Mittelhauser, A., Zhan, L., Kononov, N., Bradford, K., & Kohn, D. B. (2025). Quantifying the mutational landscape of retroviral and lentiviral vectors in gene therapy patients. Molecular Therapy, 33(9), 4459-4470. https://doi.org/10.1016/j.ymthe.2025.05.034
Vancouver
Hart KL, Crisostomo RV, Mittelhauser A, Zhan L, Kononov N, Bradford K, et al. Quantifying the mutational landscape of retroviral and lentiviral vectors in gene therapy patients. Molecular Therapy. 2025;33(9):4459-4470. doi:10.1016/j.ymthe.2025.05.034
BibTeX
@article{Hart2025,
author = {Hart, Kevyn L and Crisostomo, Ralph Valentine and Mittelhauser, Annika and Zhan, Lingyu and Kononov, Nika and Bradford, Kathryn and Kohn, Donald B},
title = {Quantifying the mutational landscape of retroviral and lentiviral vectors in gene therapy patients},
journal = {Molecular Therapy},
year = {2025},
volume = {33},
number = {9},
pages = {4459--4470},
doi = {10.1016/j.ymthe.2025.05.034}
}
EUVIMED